Advanced Progress of Histone Deacetylases in Rheumatic Diseases

References

• Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6(4):a018713. doi:10.1101/cshperspect.a018713
   PubMed Web of Science ®Google Scholar
• Asfaha Y, Schrenk C, Alves Avelar LA, et al. Recent advances in class IIa histone deacetylases research. Bioorg Med Chem. 2019;27(22):115087. doi:10.1016/j.bmc.2019.115087
   PubMed Web of Science ®Google Scholar
• Yang XJ, Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol. 2008;9(3):206–218. doi:10.1038/nrm2346
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Guarente L. Sirtuins at a glance. J Cell Sci. 2011;124(Pt 6):833–838. doi:10.1242/jcs.081067
   PubMed Web of Science ®Google Scholar
• Hawtree S, Muthana M, Wilkinson JM, Akil M, Wilson AG. Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis. Hum Mol Genet. 2015;24(19):5367–5377. doi:10.1093/hmg/ddv258
   PubMed Web of Science ®Google Scholar
• de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589–598. doi:10.1136/ard.2006.061853
   PubMed Web of Science ®Google Scholar
• Meng Q, Pan B, Sheng P. Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis. Clin Exp Rheumatol. 2021;39(5):970–981. doi:10.55563/clinexprheumatol/1xsigp
   PubMed Web of Science ®Google Scholar
• Algate K, Haynes D, Fitzsimmons T, et al. Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro. J Cell Biochem. 2020;121(1):244–258. doi:10.1002/jcb.29137
   PubMed Web of Science ®Google Scholar
• Yuan H, Jiao L, Yu N, Duan H, Yu Y, Bai Y. Histone deacetylase 3-mediated inhibition of microRNA-19a-3p facilitates the development of rheumatoid arthritis-associated interstitial lung disease. Front Physiol. 2020;11:549656. doi:10.3389/fphys.2020.549656
   PubMed Web of Science ®Google Scholar
• Kim DS, Kwon JE, Lee SH, et al. Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells. Front Immunol. 2018;9:1525. doi:10.3389/fimmu.2018.01525
   PubMed Web of Science ®Google Scholar
• Chen J, Peng L, Zhao Z, et al. HDAC1 potentiates CD4 + T cell activation by inhibiting miR-124 and promoting IRF1 in systemic lupus erythematosus. Cell Immunol. 2021;362:104284. doi:10.1016/j.cellimm.2021.104284
   PubMed Web of Science ®Google Scholar
• Zeng Y, He R, Liu Y, et al. HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway. J Orthop Surg Res. 2022;17(1):343. doi:10.1186/s13018-022-03224-z
   PubMed Web of Science ®Google Scholar
• Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol. 2013;173(1):47–57. doi:10.1111/cei.12089
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen X, Lin J, et al. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene. 2012;31(24):3002–3008. doi:10.1038/onc.2011.470
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou N, Wang W, Yu Y, Xia L, Li N. HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis. Arthritis Res Ther. 2021;23(1):78. doi:10.1186/s13075-020-02373-y
   PubMed Web of Science ®Google Scholar
• Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N, Di Cesare PE. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem. 2004;279(45):47081–47091. doi:10.1074/jbc.M405288200
   PubMed Web of Science ®Google Scholar
• Hong S, Derfoul A, Pereira-Mouries L, Hall DJ. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB j. 2009;23(10):3539–3552. doi:10.1096/fj.09-133215
   PubMed Web of Science ®Google Scholar
• Huh YH, Ryu JH, Chun JS. Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J Biol Chem. 2007;282(23):17123–17131. doi:10.1074/jbc.M700599200
   PubMed Web of Science ®Google Scholar
• Shao L, Hou C. miR-138 activates NF-κB signaling and PGRN to promote rheumatoid arthritis via regulating HDAC4. Biochem Biophys Res Commun. 2019;519(1):166–171. doi:10.1016/j.bbrc.2019.08.092
   PubMed Web of Science ®Google Scholar
• Chang L, Kan L. Mesenchymal stem cell-originated exosomal circular RNA circFBXW7 attenuates cell proliferation, migration and inflammation of fibroblast-like synoviocytes by targeting miR-216a-3p/HDAC4 in rheumatoid arthritis. J Inflamm Res. 2021;14:6157–6171. doi:10.2147/JIR.S336099
   PubMed Web of Science ®Google Scholar
• Li M, Hu W, Wang R, et al. Sp1 S-sulfhydration induced by hydrogen sulfide inhibits inflammation via HDAC6/MyD88/NF-κB signaling pathway in adjuvant-induced arthritis. Antioxidants. 2022;11:4.
   Web of Science ®Google Scholar
• Ren J, Catalina MD, Eden K, et al. Selective histone deacetylase 6 inhibition normalizes B cell activation and germinal center formation in a model of systemic lupus erythematosus. Front Immunol. 2019;10:2512. doi:10.3389/fimmu.2019.02512
   PubMed Web of Science ®Google Scholar
• Sun H, Guo F, Xu L. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9. J Cell Biochem. 2020;121(10):4310–4320. doi:10.1002/jcb.29624
   PubMed Web of Science ®Google Scholar
• Hwang I, Lee E, Jeon SA, Yu JW. Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation. Biochem Biophys Res Commun. 2015;467(4):973–978. doi:10.1016/j.bbrc.2015.10.033
   PubMed Web of Science ®Google Scholar
• Cao K, Wei L, Zhang Z, et al. Decreased histone deacetylase 4 is associated with human osteoarthritis cartilage degeneration by releasing histone deacetylase 4 inhibition of runt-related transcription factor-2 and increasing osteoarthritis-related genes: a novel mechanism of human osteoarthritis cartilage degeneration. Arthritis Res Ther. 2014;16(6):491. doi:10.1186/s13075-014-0491-3
   PubMed Web of Science ®Google Scholar
• Higashiyama R, Miyaki S, Yamashita S, et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod Rheumatol. 2010;20(1):11–17. doi:10.3109/s10165-009-0224-7
   PubMed Web of Science ®Google Scholar
• Kong S, McBurney MW, Fang D. Sirtuin 1 in immune regulation and autoimmunity. Immunol Cell Biol. 2012;90(1):6–13. doi:10.1038/icb.2011.102
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Xiao F, et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway. Biochem Pharmacol. 2016;101:100–111. doi:10.1016/j.bcp.2015.11.027
   PubMed Web of Science ®Google Scholar
• Zhang R, Chen HZ, Liu JJ, et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem. 2010;285(10):7097–7110. doi:10.1074/jbc.M109.038604
   PubMed Web of Science ®Google Scholar
• Zu B, Liu L, Wang J, Li M, Yang J. MiR-140-3p inhibits the cell viability and promotes apoptosis of synovial fibroblasts in rheumatoid arthritis through targeting sirtuin 3. J Orthop Surg Res. 2021;16(1):105. doi:10.1186/s13018-021-02236-5
   PubMed Web of Science ®Google Scholar
• Woo SJ, Noh HS, Lee NY, et al. Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium. EBioMedicine. 2018;38:228–237. doi:10.1016/j.ebiom.2018.11.005
   PubMed Web of Science ®Google Scholar
• Wang Q, Yan C, Xin M, Han L, Zhang Y, Sun M. Sirtuin 1 (Sirt1) overexpression in BaF3 cells contributes to cell proliferation promotion, apoptosis resistance and pro-inflammatory cytokine production. Med Sci Monit. 2017;23:1477–1482. doi:10.12659/MSM.900754
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298(3):E419–E428. doi:10.1152/ajpendo.00417.2009
   PubMed Web of Science ®Google Scholar
• Yao Q, Wu Q, Xu X, et al. Resveratrol ameliorates systemic sclerosis via suppression of fibrosis and inflammation through activation of SIRT1/mTOR signaling. Drug Des Devel Ther. 2020;14:5337–5348. doi:10.2147/DDDT.S281209
   PubMed Web of Science ®Google Scholar
• Wyman AE, Noor Z, Fishelevich R, et al. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2017;312(6):L945–L958. doi:10.1152/ajplung.00473.2016
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu X, Zhao T, Yu Y, Xue Y, Zou H. Sirt1 ameliorates monosodium urate crystal-induced inflammation by altering macrophage polarization via the PI3K/Akt/STAT6 pathway. Rheumatology. 2019;58(9):1674–1683. doi:10.1093/rheumatology/kez165
   PubMed Web of Science ®Google Scholar
• Li W, Cai L, Zhang Y, Cui L, Shen G. Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α. J Orthop Res. 2015;33(7):1061–1070. doi:10.1002/jor.22859
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen L, Wang Y, et al. Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development. Sci Rep. 2015;5(1):17602. doi:10.1038/srep17602
   PubMed Web of Science ®Google Scholar
• Klein K, Gay S. Epigenetics in rheumatoid arthritis. Curr Opin Rheumatol. 2015;27(1):76–82. doi:10.1097/BOR.0000000000000128
   PubMed Web of Science ®Google Scholar
• Balandraud N, Roudier J. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine. 2018;85(2):165–170. doi:10.1016/j.jbspin.2017.04.011
   PubMed Web of Science ®Google Scholar
• Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(3):141–153. doi:10.1038/nrrheum.2012.237
   PubMed Web of Science ®Google Scholar
• Guo J, Cao X, Zhao W, et al. MicroRNA-449 targets histone deacetylase 1 to regulate the proliferation, invasion, and apoptosis of synovial fibroblasts in rheumatoid arthritis. Ann Palliat Med. 2021;10(7):7960–7969. doi:10.21037/apm-21-1383
   PubMed Web of Science ®Google Scholar
• Göschl L, Preglej T, Boucheron N, et al. Histone deacetylase 1 (HDAC1): a key player of T cell-mediated arthritis. J Autoimmun. 2020;108:102379. doi:10.1016/j.jaut.2019.102379
   PubMed Web of Science ®Google Scholar
• Juge PA, Borie R, Kannengiesser C, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. 2017;49(5):1602314. doi:10.1183/13993003.02314-2016
   PubMed Web of Science ®Google Scholar
• Paulin F, Doyle TJ, Fletcher EA, Ascherman DP, Rosas IO. Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease mechanisms. Rev Invest Clin. 2015;67(5):280–286.
   PubMedGoogle Scholar
• Wang Y, Frank DB, Morley MP, et al. HDAC3-dependent epigenetic pathway controls lung alveolar epithelial cell remodeling and spreading via miR-17-92 and TGF-β signaling regulation. Dev Cell. 2016;36(3):303–315. doi:10.1016/j.devcel.2015.12.031
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang D, Wang L, et al. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L487–L497. doi:10.1152/ajplung.00301.2018
   PubMed Web of Science ®Google Scholar
• Angiolilli C, Kabala PA, Grabiec AM, et al. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis. 2017;76(1):277–285. doi:10.1136/annrheumdis-2015-209064
   PubMed Web of Science ®Google Scholar
• Wei J, Hettinghouse A, Liu C. The role of progranulin in arthritis. Ann N Y Acad Sci. 2016;1383(1):5–20. doi:10.1111/nyas.13191
   PubMedGoogle Scholar
• Hao J, Chen Y, Yu Y. Circular RNA circ_0008360 inhibits the proliferation, migration, and inflammation and promotes apoptosis of fibroblast-like synoviocytes by regulating miR-135b-5p/HDAC4 axis in rheumatoid arthritis. Inflammation. 2022;45(1):196–211. doi:10.1007/s10753-021-01538-4
   PubMed Web of Science ®Google Scholar
• Li G, Jiang H, Chang M, Xie H, Hu L. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases. J Neurol Sci. 2011;304(1–2):1–8. doi:10.1016/j.jns.2011.02.017
   PubMed Web of Science ®Google Scholar
• Menden H, Xia S, Mabry SM, et al. Histone deacetylase 6 regulates endothelial MyD88-dependent canonical TLR signaling, lung inflammation, and alveolar remodeling in the developing lung. Am J Physiol Lung Cell Mol Physiol. 2019;317(3):L332–L346. doi:10.1152/ajplung.00247.2018
   PubMed Web of Science ®Google Scholar
• Wendling D, Vidon C, Abbas W, Guillot X, Toussirot E, Herbein G. Sirt1 activity in peripheral blood mononuclear cells from patients with rheumatoid arthritis. Joint Bone Spine. 2014;81(5):462–463. doi:10.1016/j.jbspin.2014.02.006
   PubMed Web of Science ®Google Scholar
• Wendling D, Abbas W, Godfrin-Valnet M, et al. Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis. PLoS One. 2015;10(3):e0119981. doi:10.1371/journal.pone.0119981
   PubMed Web of Science ®Google Scholar
• Li G, Xia Z, Liu Y, et al. SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-κB pathway. Biosci Rep. 2018;38:3.
   Web of Science ®Google Scholar
• Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP. Mitochondrial SIRT3 and heart disease. Cardiovasc Res. 2010;88(2):250–256. doi:10.1093/cvr/cvq250
   PubMed Web of Science ®Google Scholar
• Kara M, Yolbaş S, Şahin C, Koca SS. Changes in sirtuin 2 and sirtuin 3 mRNA expressions in rheumatoid arthritis. Eur J Rheumatol. 2017;4(2):83–86. doi:10.5152/eurjrheum.2017.16056
   PubMedGoogle Scholar
• Kawahara TL, Michishita E, Adler AS, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009;136(1):62–74. doi:10.1016/j.cell.2008.10.052
   PubMed Web of Science ®Google Scholar
• Hou KL, Lin SK, Chao LH, et al. Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-A therapeutic implication in inflammatory bone resorption. Biofactors. 2017;43(2):170–180. doi:10.1002/biof.1320
   PubMed Web of Science ®Google Scholar
• D’Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369(9561):587–596. doi:10.1016/S0140-6736(07)60279-7
   PubMed Web of Science ®Google Scholar
• Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81–ITC96. doi:10.7326/AITC202006020
   PubMed Web of Science ®Google Scholar
• Gatto M, Zen M, Ghirardello A, et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev. 2013;12(4):523–536. doi:10.1016/j.autrev.2012.09.003
   PubMed Web of Science ®Google Scholar
• Nawrocki MJ, Strugała AJ, Piotrowski P, Wudarski M, Olesińska M, Jagodziński PP. JHDM1D and HDAC1-3 mRNA expression levels in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Z Rheumatol. 2015;74(10):902–910. doi:10.1007/s00393-015-1619-9
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 2006;203(1):7–13. doi:10.1084/jem.20050466
   PubMed Web of Science ®Google Scholar
• Choi EW, Song JW, Ha N, Choi YI, Kim S. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus. Sci Rep. 2018;8(1):17297. doi:10.1038/s41598-018-35602-1
   PubMedGoogle Scholar
• Yang C, Li R, Xu WD, Huang AF. Increased levels of sirtuin-1 in systemic lupus erythematosus. Int J Rheum Dis. 2022;25(8):869–876. doi:10.1111/1756-185X.14360
   PubMed Web of Science ®Google Scholar
• Broen JC, Coenen MJ, Radstake TR. Genetics of systemic sclerosis: an update. Curr Rheumatol Rep. 2012;14(1):11–21. doi:10.1007/s11926-011-0221-7
   PubMed Web of Science ®Google Scholar
• Hasegawa M. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis. J Dermatol. 2010;37(1):3–10. doi:10.1111/j.1346-8138.2009.00763.x
   PubMed Web of Science ®Google Scholar
• Gianchecchi E, Fierabracci A. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: a molecule with a dual activity. Antioxidants. 2020;9(2):2. doi:10.3390/antiox9020091
   Web of Science ®Google Scholar
• Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 2014;25(3):138–145. doi:10.1016/j.tem.2013.12.001
   PubMed Web of Science ®Google Scholar
• Guarente L. Calorie restriction and sirtuins revisited. Genes Dev. 2013;27(19):2072–2085. doi:10.1101/gad.227439.113
   PubMed Web of Science ®Google Scholar
• Lee IH, Chathuranga K, Lee J-S. Mechanisms and disease implications of sirtuin-mediated autophagic regulation. Exp Mol Med. 2019;51(9):1–11. doi:10.1038/s12276-019-0299-y
   Google Scholar
• Barber MF, Michishita-Kioi E, Xi Y, et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 2012;487(7405):114–118. doi:10.1038/nature11043
   PubMed Web of Science ®Google Scholar
• Kabel AM, Omar MS, Elmaaboud MAA. Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress. Int Immunopharmacol. 2016;39:335–342. doi:10.1016/j.intimp.2016.08.008
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Choi HK, Joosten LAB, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. doi:10.1038/s41572-019-0115-y
   PubMed Web of Science ®Google Scholar
• Galozzi P, Bindoli S, Doria A, Oliviero F, Sfriso P. Autoinflammatory features in gouty arthritis. J Clin Med. 2021;10(9):1880. doi:10.3390/jcm10091880
   PubMed Web of Science ®Google Scholar
• Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med. 2020;76:100889. doi:10.1016/j.mam.2020.100889
   PubMed Web of Science ®Google Scholar
• Danielski LG, Giustina AD, Bonfante S, Barichello T, Petronilho F. The NLRP3 inflammasome and its role in sepsis development. Inflammation. 2020;43(1):24–31. doi:10.1007/s10753-019-01124-9
   PubMed Web of Science ®Google Scholar
• Irrera N, Russo M, Pallio G, et al. The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. Int J Mol Sci. 2020;21(17):6204. doi:10.3390/ijms21176204
   PubMed Web of Science ®Google Scholar
• Yang QB, He YL, Zhong XW, Xie WG, Zhou JG. Resveratrol ameliorates gouty inflammation via upregulation of sirtuin 1 to promote autophagy in gout patients. Inflammopharmacology. 2019;27(1):47–56. doi:10.1007/s10787-018-00555-4
   PubMed Web of Science ®Google Scholar
• Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis--insights into pathogenesis. Nat Rev Rheumatol. 2016;12(2):81–91. doi:10.1038/nrrheum.2015.133
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun Y, Li Y, et al. Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker. BMC Immunol. 2018;19(1):38. doi:10.1186/s12865-018-0280-x
   PubMedGoogle Scholar
• Taurog JD, Chhabra A, Colbert RA, Longo DL. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 2016;374(26):2563–2574. doi:10.1056/NEJMra1406182
   PubMed Web of Science ®Google Scholar
• Ota H, Akishita M, Akiyoshi T, et al. Testosterone deficiency accelerates neuronal and vascular aging of SAMP8 mice: protective role of eNOS and SIRT1. PLoS One. 2012;7(1):e29598. doi:10.1371/journal.pone.0029598
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang L. Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1α expression in peripheral blood mononuclear cells. Mol Med Rep. 2016;13(1):35–40. doi:10.3892/mmr.2015.4494
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen Y, Lu X, et al. Inhibition of histone deacetylase 6 by tubastatin a attenuates the progress of osteoarthritis via improving mitochondrial function. Am J Pathol. 2020;190(12):2376–2386. doi:10.1016/j.ajpath.2020.08.013
   PubMed Web of Science ®Google Scholar
• Lambova SN, Müller-Ladner U. Osteoarthritis - current insights in pathogenesis, diagnosis and treatment. Curr Rheumatol Rev. 2018;14(2):91–97. doi:10.2174/157339711402180706144757
   PubMed Web of Science ®Google Scholar